The pooled analysis revealed that the incidence of colorectal cancer was not significantly associated with GLP-1 RAs compared to other drugs (OR: 1.73 [0.21–14.18], p = 0.61, I2 = 100%), as shown in Fig. 4. The gene discussed is GLP1R; the disease is colorectal cancer.